[New and potential biomarkers of acute kidney damage.]
The review presents literature data on the efficacy of new and potential biomarkers for the early diagnosis of acute renal damage. Early non-invasive and cost-effective kidney damage biomarkers are vital for determining the tactics, effectiveness and prognosis of treatment. Their use will not only reduce morbidity and mortality, but also reduce health care costs.